United States Biotechnology & Medical Research

Alumis Inc (ALMS)

Track

Over the past 90 days, Alumis Inc. recorded two insider transactions, both involving a sale by the Chief Legal Officer totaling $140,000. This follows a period of significant buying activity earlier in the year. The stock is currently trading near its 52-week high, following a positive earnings report in May.
Ticker: ALMS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Alumis Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Pangali Sanam
Chief Legal Officer
1 sale — total 100,000 USD
Sale 6 Jul 2026
Value US$3,225,655.55 | Price 285.60 | Shares 52,720
Proposed sale 6 Jul 2026
Value US$4,083,223.00 | Price 432.83 | Shares 88,247
Buy 9 Jan 2026
Value US$9,999,995.00 | Price 17.00 | Shares 588,235
Buy 8 Jan 2026
Value US$4,999,989.00 | Price 17.00 | Shares 294,117
Buy 8 Jan 2026
Value US$1,999,999.00 | Price 17.00 | Shares 117,647
Buy 8 Jan 2026
Value US$4,999,989.00 | Price 17.00 | Shares 294,117
Buy 8 Jan 2026
Value US$1,999,999.00 | Price 17.00 | Shares 117,647
Buy 8 Jan 2026
Value US$4,999,989.00 | Price 17.00 | Shares 294,117
Buy 8 Jan 2026
Value US$1,999,999.00 | Price 17.00 | Shares 117,647
Buy 5 Dec 2025
Value US$551,307.40 | Price 10.73 | Shares 51,380
Buy 5 Dec 2025
Value US$700,980.28 | Price 10.01 | Shares 70,028
Buy 5 Dec 2025
Value US$581,472.55 | Price 8.95 | Shares 64,969
Buy 4 Dec 2025
Value US$540,100.86 | Price 8.18 | Shares 66,027
Buy 3 Dec 2025
Value US$775,000.00 | Price 7.75 | Shares 100,000
Buy 2 Dec 2025
Value US$724,800.00 | Price 7.55 | Shares 96,000
Buy 1 Dec 2025
Value US$644,171.00 | Price 7.46 | Shares 86,350
Buy 28 Nov 2025
Value US$295,683.28 | Price 7.64 | Shares 38,702
Buy 26 Nov 2025
Value US$370,822.68 | Price 7.64 | Shares 48,537
Buy 21 Nov 2025
Value US$532,924.56 | Price 7.38 | Shares 72,212
Buy 21 Nov 2025
Value US$532,924.56 | Price 7.38 | Shares 72,212
Buy 21 Nov 2025
Value US$532,924.56 | Price 7.38 | Shares 72,212
Buy 20 Nov 2025
Value US$905,349.60 | Price 7.20 | Shares 125,743
Buy 19 Nov 2025
Value US$1,249,680.00 | Price 6.56 | Shares 190,500
Buy 19 Nov 2025
Value US$1,249,680.00 | Price 6.56 | Shares 190,500
Buy 19 Nov 2025
Value US$1,249,680.00 | Price 6.56 | Shares 190,500
Buy 19 Nov 2025
Value US$903,784.32 | Price 6.56 | Shares 137,772
Buy 18 Nov 2025
Value US$726,545.06 | Price 6.19 | Shares 117,374
Buy 18 Nov 2025
Value US$726,545.06 | Price 6.19 | Shares 117,374
Buy 18 Nov 2025
Value US$726,545.06 | Price 6.19 | Shares 117,374
Buy 18 Nov 2025
Value US$621,044.60 | Price 6.05 | Shares 102,652
Buy 17 Nov 2025
Value US$838,500.00 | Price 5.59 | Shares 150,000
Buy 17 Nov 2025
Value US$280,000.00 | Price 5.60 | Shares 50,000
Buy 17 Nov 2025
Value US$838,500.00 | Price 5.59 | Shares 150,000
Buy 17 Nov 2025
Value US$280,000.00 | Price 5.60 | Shares 50,000
Buy 17 Nov 2025
Value US$838,500.00 | Price 5.59 | Shares 150,000
Buy 17 Nov 2025
Value US$280,000.00 | Price 5.60 | Shares 50,000
Buy 17 Nov 2025
Value US$5,036.14 | Price 5.51 | Shares 914
Buy 13 Nov 2025
Value US$1,449,939.75 | Price 5.25 | Shares 276,179
Buy 6 May 2025
Value US$86,800.00 | Price 4.34 | Shares 20,000
Buy 6 May 2025
Value US$86,800.00 | Price 4.34 | Shares 20,000
Buy 6 May 2025
Value US$86,800.00 | Price 4.34 | Shares 20,000
Buy 5 May 2025
Value US$115,950.54 | Price 5.27 | Shares 22,002
Buy 5 May 2025
Value US$633,725.44 | Price 4.58 | Shares 138,368
Buy 2 May 2025
Value US$115,500.00 | Price 4.62 | Shares 25,000
Buy 2 May 2025
Value US$115,500.00 | Price 4.62 | Shares 25,000
Buy 2 May 2025
Value US$115,500.00 | Price 4.62 | Shares 25,000
Buy 2 May 2025
Value US$727,636.00 | Price 4.55 | Shares 159,920
Buy 2 Apr 2025
Value US$17,235.05 | Price 7.49 | Shares 2,300
Buy 1 Apr 2025
Value US$100,732.79 | Price 6.44 | Shares 15,650
Buy 1 Apr 2025
Value US$112,309.30 | Price 6.97 | Shares 16,104
Buy 1 Jul 2024
Value US$35,000,000.00 | Price 16.00 | Shares 2,187,500
Buy 1 Jul 2024
Value US$5,000,000.00 | Price 16.00 | Shares 312,500
Buy 1 Jul 2024
Value US$35,000,000.00 | Price 16.00 | Shares 2,187,500
Buy 1 Jul 2024
Value US$5,000,000.00 | Price 16.00 | Shares 312,500
Buy 1 Jul 2024
Value US$35,000,000.00 | Price 16.00 | Shares 2,187,500
Buy 1 Jul 2024
Value US$5,000,000.00 | Price 16.00 | Shares 312,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-08 2026-07-06 S Sale
Pangali Sanam

Chief Legal Officer

Officer
52,720 -40.5%
285.60
US$3,225,656 		52,720 -40.5% 285.60 US$3,225,656
2026-07-06 2026-07-06 PrS Proposed sale
SANAMPREET PANGALI

Officer

Officer
88,247
432.83
US$4,083,223 		88,247 432.83 US$4,083,223
2026-01-13 2026-01-09 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
49,103 +25.6%
245.39
US$2,580,898 		49,103 +25.6% 245.39 US$2,580,898
2026-01-12 2026-01-08 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
294,117 +11.3%
17.00
US$4,999,989 		294,117 +11.3% 17.00 US$4,999,989
2026-01-12 2026-01-08 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
117,647 +2.1%
17.00
US$1,999,999 		117,647 +2.1% 17.00 US$1,999,999
2026-01-12 2026-01-08 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
294,117 +11.3%
17.00
US$4,999,989 		294,117 +11.3% 17.00 US$4,999,989
2026-01-12 2026-01-08 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
117,647 +2.1%
17.00
US$1,999,999 		117,647 +2.1% 17.00 US$1,999,999
2026-01-12 2026-01-08 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
294,117 +11.3%
17.00
US$4,999,989 		294,117 +11.3% 17.00 US$4,999,989
2026-01-12 2026-01-08 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
117,647 +2.1%
17.00
US$1,999,999 		117,647 +2.1% 17.00 US$1,999,999
2025-12-09 2025-12-05 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
51,380 +4.2%
10.73
US$551,307 		51,380 +4.2% 10.73 US$551,307
2025-12-09 2025-12-05 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
70,028 +6.1%
10.01
US$700,980 		70,028 +6.1% 10.01 US$700,980
2025-12-09 2025-12-05 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
64,969 +6.0%
8.95
US$581,473 		64,969 +6.0% 8.95 US$581,473
2025-12-04 2025-12-04 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
66,027 +6.5%
8.18
US$540,101 		66,027 +6.5% 8.18 US$540,101
2025-12-04 2025-12-03 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
100,000 +11.0%
7.75
US$775,000 		100,000 +11.0% 7.75 US$775,000
2025-12-04 2025-12-02 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
96,000 +11.8%
7.55
US$724,800 		96,000 +11.8% 7.55 US$724,800
2025-12-01 2025-12-01 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
86,350 +11.8%
7.46
US$644,171 		86,350 +11.8% 7.46 US$644,171
2025-12-01 2025-11-28 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
38,702 +5.6%
7.64
US$295,683 		38,702 +5.6% 7.64 US$295,683
2025-12-01 2025-11-26 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
48,537 +7.5%
7.64
US$370,823 		48,537 +7.5% 7.64 US$370,823
2025-11-25 2025-11-21 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
72,212 +2.8%
7.38
US$532,925 		72,212 +2.8% 7.38 US$532,925
2025-11-25 2025-11-21 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
72,212 +2.8%
7.38
US$532,925 		72,212 +2.8% 7.38 US$532,925
2025-11-25 2025-11-21 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
72,212 +2.8%
7.38
US$532,925 		72,212 +2.8% 7.38 US$532,925
2025-11-24 2025-11-20 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
125,743 +24.3%
7.20
US$905,350 		125,743 +24.3% 7.20 US$905,350
2025-11-19 2025-11-19 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
190,500 +8.1%
6.56
US$1,249,680 		190,500 +8.1% 6.56 US$1,249,680
2025-11-19 2025-11-19 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
190,500 +8.1%
6.56
US$1,249,680 		190,500 +8.1% 6.56 US$1,249,680
2025-11-19 2025-11-19 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
190,500 +8.1%
6.56
US$1,249,680 		190,500 +8.1% 6.56 US$1,249,680
2025-11-19 2025-11-19 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
137,772 +36.3%
6.56
US$903,784 		137,772 +36.3% 6.56 US$903,784
2025-11-19 2025-11-18 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
117,374 +5.3%
6.19
US$726,545 		117,374 +5.3% 6.19 US$726,545
2025-11-19 2025-11-18 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
117,374 +5.3%
6.19
US$726,545 		117,374 +5.3% 6.19 US$726,545
2025-11-19 2025-11-18 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
117,374 +5.3%
6.19
US$726,545 		117,374 +5.3% 6.19 US$726,545
2025-11-19 2025-11-18 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
102,652 +37.0%
6.05
US$621,045 		102,652 +37.0% 6.05 US$621,045
2025-11-19 2025-11-17 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
150,000 +7.2%
5.59
US$838,500 		150,000 +7.2% 5.59 US$838,500
2025-11-19 2025-11-17 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
50,000 +2.5%
5.60
US$280,000 		50,000 +2.5% 5.60 US$280,000
2025-11-19 2025-11-17 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
150,000 +7.2%
5.59
US$838,500 		150,000 +7.2% 5.59 US$838,500
2025-11-19 2025-11-17 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
50,000 +2.5%
5.60
US$280,000 		50,000 +2.5% 5.60 US$280,000
2025-11-19 2025-11-17 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
150,000 +7.2%
5.59
US$838,500 		150,000 +7.2% 5.59 US$838,500
2025-11-19 2025-11-17 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
50,000 +2.5%
5.60
US$280,000 		50,000 +2.5% 5.60 US$280,000
2025-11-19 2025-11-17 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
914 +0.3%
5.51
US$5,036 		914 +0.3% 5.51 US$5,036
2025-11-17 2025-11-13 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
276,179 +inf%
5.25
US$1,449,940 		276,179 +inf% 5.25 US$1,449,940
2025-05-06 2025-05-06 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
20,000 +0.5%
4.34
US$86,800 		20,000 +0.5% 4.34 US$86,800
2025-05-06 2025-05-06 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
20,000 +0.5%
4.34
US$86,800 		20,000 +0.5% 4.34 US$86,800
2025-05-06 2025-05-06 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
20,000 +0.5%
4.34
US$86,800 		20,000 +0.5% 4.34 US$86,800
2025-05-06 2025-05-05 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
22,002 +0.6%
5.27
US$115,951 		22,002 +0.6% 5.27 US$115,951
2025-05-06 2025-05-05 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
138,368 +4.0%
4.58
US$633,725 		138,368 +4.0% 4.58 US$633,725
2025-05-06 2025-05-02 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
25,000 +0.6%
4.62
US$115,500 		25,000 +0.6% 4.62 US$115,500
2025-05-06 2025-05-02 B Purchase
4.1
Foresite Capital Management VI LLC
Large shareholder
25,000 +0.6%
4.62
US$115,500 		25,000 +0.6% 4.62 US$115,500
2025-05-06 2025-05-02 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
25,000 +0.6%
4.62
US$115,500 		25,000 +0.6% 4.62 US$115,500
2025-05-06 2025-05-02 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
159,920 +4.9%
4.55
US$727,636 		159,920 +4.9% 4.55 US$727,636
2025-04-03 2025-04-02 B Purchase
0.8
Colowick Alan
Non-Executive Director
2,300 +14.3%
7.49
US$17,235 		2,300 +14.3% 7.49 US$17,235
2025-04-03 2025-04-01 B Purchase
0.5
Babler Martin

President, CEO and Chairman

Executive Director
15,650 +17.2%
6.44
US$100,733 		15,650 +17.2% 6.44 US$100,733
2025-04-03 2025-04-01 B Purchase
0.8
Colowick Alan
Non-Executive Director
16,104 +inf%
6.97
US$112,309 		16,104 +inf% 6.97 US$112,309
2024-07-03 2024-07-01 B Purchase
3.4
Foresite Capital Management V, LLC
Large shareholder
2,187,500 +108.6%
16.00
US$35,000,000 		2,187,500 +108.6% 16.00 US$35,000,000
2024-07-03 2024-07-01 B Purchase
3.4
Foresite Capital Management V, LLC
Large shareholder
312,500 +5.9%
16.00
US$5,000,000 		312,500 +5.9% 16.00 US$5,000,000
2024-07-03 2024-07-01 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
2,187,500 +108.6%
16.00
US$35,000,000 		2,187,500 +108.6% 16.00 US$35,000,000
2024-07-03 2024-07-01 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
312,500 +5.9%
16.00
US$5,000,000 		312,500 +5.9% 16.00 US$5,000,000
2024-07-03 2024-07-01 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
2,187,500 +108.6%
16.00
US$35,000,000 		2,187,500 +108.6% 16.00 US$35,000,000
2024-07-03 2024-07-01 B Purchase
4.1
Foresite Labs, LLC
Large shareholder
312,500 +5.9%
16.00
US$5,000,000 		312,500 +5.9% 16.00 US$5,000,000
Explore more

More insider trading research around Alumis Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America